Literature DB >> 8568252

Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells.

R Malaviya1, N J Twesten, E A Ross, S N Abraham, J D Pfeifer.   

Abstract

The pivotal role of mast cells in allergic reactions and inflammatory processes is well established and recent studies have suggested that mast cells may also have a role in specific immune responses. Because mast cells have been shown to phagocytose and kill enterobacteria, we wished to determine whether they could also process bacterial Ags for presentation to T cells. Using a model system in which a well-characterized T cell epitope is expressed within bacteria as a fusion protein, we demonstrate in this paper that mast cells are indeed capable of processing bacterial Ags for presentation through class I MHC molecules to T cell hybridomas after phagocytic uptake of live bacteria. Processing occurs from a number of Gram-negative enterobacteria including Salmonella typhimurium and Escherichia coli. Parallel assays show that processing of the model Ag from enterobacteria by mast cells is similar in efficiency to processing by peritoneal macrophages. Consistent with earlier observations demonstrating a function of the bacterial fimbrial protein FimH in promoting bacterial binding to mast cells, the magnitude of the Ag processing response of E. coli is influenced by bacterial expression of FimH. Taken together, these observations extend the range of cell types capable of the phagocytic pathway of Ag processing and suggest that mast cells may have a previously unrecognized role in the induction of specific immune responses to bacteria.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8568252

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  Mast cell function is not altered by Coronin-1A deficiency.

Authors:  Sanja Arandjelovic; Dilki Wickramarachchi; Saskia Hemmers; Sunamita S Leming; Dwight H Kono; Kerri A Mowen
Journal:  J Leukoc Biol       Date:  2010-07-19       Impact factor: 4.962

2.  Hematopoietic stem-cell transplantation for advanced systemic mastocytosis.

Authors:  Celalettin Ustun; Andreas Reiter; Bart L Scott; Ryotaro Nakamura; Gandhi Damaj; Sebastian Kreil; Ryan Shanley; William J Hogan; Miguel-Angel Perales; Tsiporah Shore; Herrad Baurmann; Robert Stuart; Bernd Gruhn; Michael Doubek; Jack W Hsu; Eleni Tholouli; Tanja Gromke; Lucy A Godley; Livio Pagano; Andrew Gilman; Eva Maria Wagner; Tor Shwayder; Martin Bornhäuser; Esperanza B Papadopoulos; Alexandra Böhm; Gregory Vercellotti; Maria Teresa Van Lint; Christoph Schmid; Werner Rabitsch; Vinod Pullarkat; Faezeh Legrand; Ibrahim Yakoub-Agha; Wael Saber; John Barrett; Olivier Hermine; Hans Hagglund; Wolfgang R Sperr; Uday Popat; Edwin P Alyea; Steven Devine; H Joachim Deeg; Daniel Weisdorf; Cem Akin; Peter Valent
Journal:  J Clin Oncol       Date:  2014-08-25       Impact factor: 44.544

Review 3.  Role of the innate immune system in the pathogenesis of multiple sclerosis.

Authors:  Roopali Gandhi; Alice Laroni; Howard L Weiner
Journal:  J Neuroimmunol       Date:  2010-04-15       Impact factor: 3.478

4.  Mast cells kill Candida albicans in the extracellular environment but spare ingested fungi from death.

Authors:  Elisa Trevisan; Francesca Vita; Nevenka Medic; Maria Rosa Soranzo; Giuliano Zabucchi; Violetta Borelli
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

5.  Bacterial immunoglobulin superantigen proteins A and L activate human heart mast cells by interacting with immunoglobulin E.

Authors:  A Genovese; J P Bouvet; G Florio; B Lamparter-Schummert; L Björck; G Marone
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

6.  Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation.

Authors:  G Raposo; D Tenza; S Mecheri; R Peronet; C Bonnerot; C Desaymard
Journal:  Mol Biol Cell       Date:  1997-12       Impact factor: 4.138

7.  Constitutive class I-restricted exogenous presentation of self antigens in vivo.

Authors:  C Kurts; W R Heath; F R Carbone; J Allison; J F Miller; H Kosaka
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

Review 8.  Mast cells in infection and immunity.

Authors:  S N Abraham; R Malaviya
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

9.  Characterization of cis-regulatory elements conferring mercury-induced interleukin-4 gene expression in rat mast cells: a role for signal transducer and activator of transcription 6 and TATA box binding sites.

Authors:  Zonglin Wu; Alex Pearson; David Oliveira
Journal:  Immunology       Date:  2009-08       Impact factor: 7.397

10.  The antigen presentation function of bone marrow-derived mast cells is spatiotemporally restricted to a subset expressing high levels of cell surface FcepsilonRI and MHC II.

Authors:  Jian Gong; Ning-Sun Yang; Michael Croft; I-Chun Weng; Liangwu Sun; Fu-Tong Liu; Swey-Shen Chen
Journal:  BMC Immunol       Date:  2010-06-30       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.